We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amphion Innovations Plc | LSE:AMP | London | Ordinary Share | GB00B0DJNP99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.15 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAMP
RNS Number : 7056E
Amphion Innovations PLC
14 April 2014
Amphion Innovations plc
DataTern Inc., Receives Favourable Appeal Ruling
London and New York, 14 April 2014 - DataTern Inc., a wholly-owned subsidiary of Amphion Innovations plc (AIM: AMP) ("Amphion" or "the Company"), has received a favourable decision on its appeal to the US Court of Appeals for the Federal Circuit. The appeal was a result of the ruling that was rendered in December 2012 by the US District Court for the Southern District of New York in the declaratory judgment actions brought by SAP and Microsoft in April 2011.
As previously announced in Amphion's RNS announcement of 17 April 2013, DataTern's appeal was based on its belief that the New York court lacked jurisdiction and that the Markman claim construction rendered on DataTern's patents was flawed.
The Federal Circuit's decision broadly found in favour of DataTern's position.
Richard Morgan, CEO of Amphion, said; "This is a good result. This ruling will allow us to continue to try to reach equitable licensing agreements with the many companies that are infringing these patents. Our goal remains to generate a fair and reasonable return on the very substantial investment we have made over many years in the development of these innovative technologies."
For further information please contact:
Amphion Innovations
Charlie Morgan
+1 212 210 6224
Novella Communications
Tim Robertson / Ben Heath
+44 020 3151 7008
Panmure Gordon Limited
Freddy Crossley / Fred Walsh / (Corporate Finance)
Adam Pollock / Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCQKBDBCBKKDQD
1 Year Amphion Innovations Chart |
1 Month Amphion Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions